Apricus Biosciences, Inc. (APRI) Reports Q3 Loss of $0.11
Tweet
Share
E-mailGet Alerts APRI Hot Sheet
Join SI Premium – FREE
Apricus Biosciences, Inc. (NASDAQ: APRI) reported Q3 EPS of ($0.11), versus ($0.20) reported last year. Revenue for the quarter came in at $799.4 thousand, versus $1.09 million reported last year.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
- Bimergen Energy Corporation (BESS) Reports Q2 EPS of $0.22
- Motorsport Games Inc. (MSGM) Tops Q2 EPS by 33c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
